GeneDx Holdings Warrant
WGSWW
WGSWW was delisted on the 21st of July, 2026.
28 hedge funds and large institutions have $73.7M invested in GeneDx Holdings Warrant in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 12 closing their positions.
465% more capital invested
Capital invested by funds: $13M → $73.7M (+$60.7M)
50% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 12
27% more funds holding
Funds holding: 22 → 28 (+6)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
+$13.9M |
| 2 |
SHCM
Sachem Head Capital Management
New York
|
+$6.42M |
| 3 |
ICM
Ionic Capital Management
New York
|
+$3.28M |
| 4 |
D.E. Shaw & Co
New York
|
+$2.77M |
| 5 |
AC
Athanor Capital
New York
|
+$2.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCIM
TOMS Capital Investment Management
New York
|
-$3.9M |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$900K |
| 3 |
SRCM
Sage Rock Capital Management
New York
|
-$773K |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$444K |
| 5 |
SC
Sculptor Capital
New York
|
-$347K |
WGSWW Hedge Fund Activity: Q1 2021 in Review
28 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q1 2021, worth a combined $73.7M — up 465% from $13M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new WGSWW positions and 12 closed out — a net gain of 6 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was SB Management, opening a new position worth an estimated $13.9M. The largest seller was TOMS Capital Investment Management, exiting entirely with an estimated $3.9M sold.
- 28 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q1 2021, up from 22 in Q4 2020.
- Funds reported $73.7M of GeneDx Holdings Warrant stock for Q1 2021, up 465% quarter-over-quarter.
- 18 funds opened new GeneDx Holdings Warrant positions in Q1 2021 and 12 closed out, a net change of +6 holders.
- The largest GeneDx Holdings Warrant buyer in Q1 2021 was SB Management, an estimated $13.9M added.
- The largest GeneDx Holdings Warrant seller in Q1 2021 was TOMS Capital Investment Management, an estimated $3.9M sold.
Based on aggregated 13F filings for Q1 2021.